Type B trichothecenes commonly contaminate cereal grains and include five structurally related congeners: deoxynivalenol (DON), 3-acetyldeoxynivalenol (3-ADON), 15-acetyldeoxynivalenol (15-ADON), fusarenon X (FX), and nivalenol (NIV). These toxins are known to have negative effects on human and animal health, particularly affecting food intake. However, the pathophysiological basis for anorexic effect is not fully clarified. The purpose of this study is to explore the potential roles of the brain-gut peptides substance P (SP) and glucagon-like peptide-17-36 amide (GLP-1) in anorexic responses induced by type B trichothecenes following both intraperitoneal (IP) and oral administration. SP and GLP-1 were elevated at 1 or 2 h and returned to basal levels at 6 h following exposure to DON and both ADONs. FX induced the production of both brain gut peptides with initial time at 1 or 2 h and duration > 6 h. Similar to FX, exposing IP to NIV caused elevations of SP and GLP-1 at 1 h and lasted more than 6 h, whereas oral exposure to NIV only increased both brain gut peptides at 2 h. The neurokinin-1 receptor (NK-1R) antagonist Emend® dose-dependently attenuated both SP- and DON-induced anorexic responses. Pretreatment with the GLP-1 receptor (GLP-1R) antagonist Exending9-39 induced a dose-dependent attenuation of both GLP-1- and DON-induced anorexic responses. To summarize, the results suggest that both SP and GLP-1 play important roles in anorexia induction by type B trichothecenes.

College of Life Science Yangtze University Jingzhou 434025 China

Department of Chemistry Faculty of Science University of Hradec Kralove 50003 Hradec Kralove Czech Republic

MOE Joint International Research Laboratory of Animal Health and Food Safety College of Veterinary Medicine Nanjing Agricultural University Nanjing 210095 China

School of Animal Husbandry and Veterinary Medicine Jiangsu Vocational College of Agriculture and Forestry Jurong 212400 China

School of Food and Biological Engineering Hefei University of Technology Hefei 230009 China

See more in PubMed

Mahato D.K., Pandhi S., Kamle M., Gupta A., Sharma B., Panda B.K., Srivastava S., Kumar M., Selvakumar R., Pandey A.K., et al. Trichothecenes in food and feed: Occurrence, impact on human health and their detection and management strategies. Toxicon. 2022;208:62–77. doi: 10.1016/j.toxicon.2022.01.011. PubMed DOI

Kumar P., Mahato D.K., Gupta A., Pandey S., Paul V., Saurabh V., Pandey A.K., Selvakumar R., Barua S., Kapri M., et al. Nivalenol Mycotoxin Concerns in Foods: An Overview on Occurrence, Impact on Human and Animal Health and Its Detection and Management Strategies. Toxins. 2022;14:527. doi: 10.3390/toxins14080527. PubMed DOI PMC

Ekwomadu T.I., Akinola S.A., Mwanza M. Fusarium Mycotoxins, Their Metabolites (Free, Emerging, and Masked), Food Safety Concerns, and Health Impacts. Int. J. Environ. Res. Public Health. 2021;18:22. doi: 10.3390/ijerph182211741. PubMed DOI PMC

Pestka J.J. Deoxynivalenol: Mechanisms of action, human exposure, and toxicological relevance. Arch. Toxicol. 2010;84:663–679. doi: 10.1007/s00204-010-0579-8. PubMed DOI

Bin-Umer M.A., McLaughlin J.E., Basu D., McCormick S., Tumer N.E. Trichothecene Mycotoxins Inhibit Mitochondrial Translation—Implication for the Mechanism of Toxicity. Toxins. 2011;3:1484–1501. doi: 10.3390/toxins3121484. PubMed DOI PMC

Wu W.D., Flannery B.M., Sugita-Konishi Y., Watanabe M., Zhang H., Pestka J.J. Comparison of murine anorectic responses to the 8-ketotrichothecenes 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, fusarenon X and nivalenol. Food Chem. Toxicol. 2012;50:2056–2061. doi: 10.1016/j.fct.2012.03.055. PubMed DOI

Wang A.K., Schwean-Lardner K., Hogan N.S. Feed preference and feeding behaviours in grower broilers fed diets containing wheat naturally contaminated with fusarium mycotoxins. Br. Poult. Sci. 2019;60:309–316. doi: 10.1080/00071668.2019.1596224. PubMed DOI

Ujcic-Vrhovnik I., Kopitar A.N., Malovrh T., Jezek J., Jakovac-Strajn B. Effects of feeding grains naturally contaminated with Fusarium toxins on selected haematological pa-rameters and lymphocyte subsets in primiparous sows. Slov. Vet. Res. 2019;56:21–29.

Rotter B.A., Prelusky D.B., Pestka J.J. Toxicology of deoxynivalenol (vomitoxin) J. Toxicol. Env. Ment. Health. 1996;48:1–34. doi: 10.1080/009841096161447. PubMed DOI

Lebrun B., Tardivel C., Félix B., Abysique A., Troadec J.-D., Gaigé S., Dallaporta M. Dysregulation of energy balance by trichothecene mycotoxins: Mechanisms and prospects. Neurotoxicology. 2015;49:15–27. doi: 10.1016/j.neuro.2015.04.009. PubMed DOI

Gaige S., Bonnet M.S., Tardivel C., Pinton P., Trouslard J., Jeas A., Guzylaxk L., Troadec J.-D., Dallaporta M. c-Fos immunoreactivity in the pig brain following deoxynivalenol intoxication: Focus on NUCB2/nesfatin-1 ex-pressing neurons. Neurotoxicology. 2013;34:135–149. doi: 10.1016/j.neuro.2012.10.020. PubMed DOI

Girardet C., Bonnet M.S., Jdir R., Sadoud M., Thirion S., Tardivel C., Roux J., Lebrun B., Wanaverbecq N., Mounien L., et al. The Food-Contaminant Deoxynivalenol Modifies Eating by Targeting Anorexigenic Neurocircuitry. PLoS ONE. 2011;6:e26134. doi: 10.1371/journal.pone.0026134. PubMed DOI PMC

Flannery B.M., Clark E.S., Pestka J.J. Anorexia Induction by the Trichothecene Deoxynivalenol (Vomitoxin) Is Mediated by the Release of the Gut Satiety Hormone Peptide YY. Toxicol. Sci. 2012;130:289–297. doi: 10.1093/toxsci/kfs255. PubMed DOI PMC

Parker J.A., Bloom S.R. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology. 2012;63:18–30. doi: 10.1016/j.neuropharm.2012.02.004. PubMed DOI

Jia H., Wu W.-D., Lu X., Zhang J., He C.-H., Zhang H.-B. Role of Glucagon-Like Peptide-1 and Gastric Inhibitory Peptide in Anorexia Induction Following Oral Exposure to the Trichothecene Mycotoxin Deoxynivalenol (Vomitoxin) Toxicol. Sci. 2017;159:16–24. doi: 10.1093/toxsci/kfx112. PubMed DOI

Peterfi Z., Szilvásy-Szabó A., Farkas E., Ruska Y., Pyke C., Knudsen L.B., Fekete C. Glucagon-like peptide-1 regulates the proopiomelanocortin neurons of the arcuate nucleus both directly and indi-rectly via presynaptic action. Neuroendocrinology. 2021;111:986–997. doi: 10.1159/000512806. PubMed DOI

DeVane C.L. Substance P: A New Era, a New Role. Pharmacotherapy. 2001;21:1061–1069. doi: 10.1592/phco.21.13.1061.34612. PubMed DOI

Hökfelt T., Pernow B., Wahren J. Substance P: A pioneer amongst neuropeptides. J. Intern. Med. 2001;249:27–40. doi: 10.1046/j.0954-6820.2000.00773.x. PubMed DOI

Szereda-Przestaszewska M., Kaczyńska K. Serotonin and substance P: Synergy or competition in the control of breathing. Auton. Neurosci. Basic Clin. 2020;225:102658. doi: 10.1016/j.autneu.2020.102658. PubMed DOI

Jessop D.S., Renshaw D., Larsen P.J., Chowdrey H.S., Harbuz M.S. Substance P Is Involved in Terminating the Hypothalamo-Pituitary-Adrenal Axis Response to Acute Stress Through Centrally Located Neurokinin-1 Receptors. Stress. 2000;3:209–220. doi: 10.3109/10253890009001125. PubMed DOI

Dib B. Food and water intake suppression by intracerebroventricular administration of substance P in food- and water-deprived rats. Brain Res. 1999;830:38–42. doi: 10.1016/S0006-8993(99)01379-7. PubMed DOI

Frisch P., Bilkei-Gorzó A., Rácz I., Zimmer A. Modulation of the CRH system by substance P/NKA in an animal model of depression. Behav. Brain Res. 2010;213:103–108. doi: 10.1016/j.bbr.2010.04.044. PubMed DOI

Larsen P.J., Holst J.J. Glucagon-related peptide 1 (GLP-1): Hormone and neurotransmitter. Regul. Pept. 2005;128:97–107. doi: 10.1016/j.regpep.2004.08.026. PubMed DOI

Liu M., Zhao L., Gong G., Zhang L., Shi L., Dai J., Han Y., Wu Y., Khalil M.M., Sun L. Invited review: Remediation strategies for mycotoxin control in feed. J. Anim. Sci. Biotechnol. 2022;13:19. doi: 10.1186/s40104-021-00661-4. PubMed DOI PMC

Eskola M., Kos G., Elliott C.T., Hajslova J., Mayar S., Krska R. Worldwide contamination of food-crops with mycotoxins: Validity of the widely cited ‘FAO estimate’ of 25% Crit. Rev. Food Sci. Nutr. 2020;60:2773–2789. doi: 10.1080/10408398.2019.1658570. PubMed DOI

Zhao L., Zhang L., Xu Z., Liu X., Chen L., Dai J., Karrow N.A., Sun L. Occurrence of Aflatoxin B1, deoxynivalenol and zearalenone in feeds in China during 2018–2020. J. Anim. Sci. Biotechnol. 2021;12:74. doi: 10.1186/s40104-021-00603-0. PubMed DOI PMC

Wu W., Zhou H.-R., Bursian S.J., Pan X., Link J.E., Berthiller F., Adam G., Krantis A., Durst T., Pestka J.J. Comparison of Anorectic and Emetic Potencies of Deoxynivalenol (Vomitoxin) to the Plant Metabolite Deoxynivalenol-3-Glucoside and Synthetic Deoxynivalenol Derivatives EN139528 and EN139544. Toxicol. Sci. 2014;142:167–181. doi: 10.1093/toxsci/kfu166. PubMed DOI PMC

Dockray G.J. Gastrointestinal hormones and the dialogue between gut and brain. J. Physiol. 2014;592:2927–2941. doi: 10.1113/jphysiol.2014.270850. PubMed DOI PMC

Byrne J., Kandel E.R. Presynaptic facilitation revisited: State and time dependence. J. Neurosci. 1996;16:425–435. doi: 10.1523/JNEUROSCI.16-02-00425.1996. PubMed DOI PMC

Zieglgänsberger W. Substance P and pain chronicity. Cell Tissue Res. 2019;375:227–241. doi: 10.1007/s00441-018-2922-y. PubMed DOI PMC

Sheng K., Lu X., Yue J., Gu W., Gu C., Zhang H., Wu W. Role of neurotransmitters 5-hydroxytryptamine and substance P in anorexia induction following oral exposure to the trichothecene T-2 toxin. Food Chem. Toxicol. 2019;123:1–8. doi: 10.1016/j.fct.2018.10.041. PubMed DOI

Euler U.S.V., Gaddum J.H. An unidentified depressor substance in certain tissue extracts. J. Physiol. 1931;72:74–87. doi: 10.1113/jphysiol.1931.sp002763. PubMed DOI PMC

Hay Kraus B.L. Spotlight on the perioperative use of maropitant citrate. Veter. Med. Res. Rep. 2017;8:41–51. doi: 10.2147/VMRR.S126469. PubMed DOI PMC

Krowicki Z.K., Hornby P.J. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat. J. Pharmacol. Exp. Ther. 2000;293:214–221. PubMed

Khazali H., Mahmoudi F. The effects of interaction between ghrelin and substance-P on mean plasma thyroid hormones concentration and body weight. Daru J. Pharm. Sci. 2009;17:109–112.

Kenny P.J. Common cellular and molecular mechanisms in obesity and drug addiction. Nat. Rev. Neurosci. 2011;12:638–651. doi: 10.1038/nrn3105. PubMed DOI

Eren-Yazicioglu C.Y., Yigit A., Dogruoz R.E., Yapici-Eser H. Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Sys-tematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol. Front. Behav. Neurosci. 2021;14:614884. doi: 10.3389/fnbeh.2020.614884. PubMed DOI PMC

Steinert R.E., Beglinger C., Langhans W. Intestinal GLP-1 and satiation: From man to rodents and back. Int. J. Obes. 2016;40:198–205. doi: 10.1038/ijo.2015.172. PubMed DOI

Vogel H., Wolf S., Rabasa C., Rodriguez-Pacheco F., Babaei C.S., Stöber F., Goldschmidt J., DiMarchi R.D., Finan B., Tschöp M.H., et al. GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight. Neuropharmacology. 2016;110:396–406. doi: 10.1016/j.neuropharm.2016.07.039. PubMed DOI

Ong Z.Y., Liu J.-J., Pang Z.P., Grill H.J. Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling. Neuropsychopharmacology. 2017;42:2387–2397. doi: 10.1038/npp.2017.150. PubMed DOI PMC

Konanur V.R., Hsu T.M., Kanoski S.E., Hayes M.R., Roitman M.F. Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4. Physiol. Behav. 2020;215:112771. doi: 10.1016/j.physbeh.2019.112771. PubMed DOI PMC

van Bloemendaal L., Kulve J.S.T., la Fleur S., Ijzerman R.G., Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: Focus on the CNS. J. Endocrinol. 2014;221:T1–T16. doi: 10.1530/JOE-13-0414. PubMed DOI

Rezaie P., Bitarafan V., Horowitz M., Feinle-Bisset C. Effects of Bitter Substances on GI Function, Energy Intake and Glycaemia-Do Preclinical Findings Translate to Outcomes in Humans? Nutrients. 2021;13:1317. doi: 10.3390/nu13041317. PubMed DOI PMC

Yu Y., Hao G., Zhang Q., Hua W., Wang M., Zhou W., Zong S., Huang M., Wen X. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem. Pharmacol. 2015;97:173–177. doi: 10.1016/j.bcp.2015.07.012. PubMed DOI

Suh H.-W., Lee K.-B., Kim K.-S., Yang H.J., Choi E.-K., Shin M.H., Park Y.S., Na Y.-C., Ahn K.S., Jang Y.P., et al. A bitter herbal medicine Gentiana scabra root extract stimulates glucagon-like peptide-1 secretion and regulates blood glucose in db/db mouse. J. Ethnopharmacol. 2015;172:219–226. doi: 10.1016/j.jep.2015.06.042. PubMed DOI

Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. Vasc. Syst. 1995;26:911–944. doi: 10.1016/0306-3623(94)00292-U. PubMed DOI

Datar P., Sudha S., Evans C., Girjesh G. Substance P: Structure, function, and therapeutics. Curr. Top. Med. Chem. 2004;4:75–103. doi: 10.2174/1568026043451636. PubMed DOI

Baggio L.L., Drucker D.J. Biology of Incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157. doi: 10.1053/j.gastro.2007.03.054. PubMed DOI

Thorens B., Porret A., Bühler L., Deng S.P., Morel P., Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes. 1993;42:1678–1682. doi: 10.2337/diab.42.11.1678. PubMed DOI

Legi A., Rodriguez E., Eckols T., Mistry C., Robinson P. Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity. Cancers. 2021;13:1732. doi: 10.3390/cancers13071732. PubMed DOI PMC